SCHEMBL7218828

SCHEMBL7218828

CC(C)CC(=O)N[C]1C=CC=CC1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.46
SMN1; SMN2 Q16637 6/20 0.44
HPGD P15428 3/20 0.41
LMNA P02545 2/20 0.41
RAB9A P51151 5/20 0.40
GAA P10253 3/20 0.40
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 3/20 0.39
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TSHR P16473 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
POLB P06746 1/20 0.37
ADORA1 P30542 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10898800 0.72 ALDH1A1 (0.34) GAAALDH1A1NPC1MAPTKDM4E
SCHEMBL778896 0.71 PTPN1 (0.45) PTPN1SMN1; SMN2HPGDLMNARAB9A
SCHEMBL13178829 0.67 PTPN1 (0.68) PTPN1SMN1; SMN2HPGDLMNARAB9A
SCHEMBL21765873 0.67 PTPN1 (0.88) PTPN1SMN1; SMN2HPGDLMNARAB9A
SCHEMBL776246 0.66 PTPN1 (0.42) PTPN1SMN1; SMN2HPGDLMNARAB9A
SCHEMBL27404748 0.65 GAA (0.48) PTPN1SMN1; SMN2HPGDLMNARAB9A
SCHEMBL17515331 0.64 HPGD (0.47) PTPN1SMN1; SMN2HPGDLMNAGAA
SCHEMBL12284941 0.64 SMN1; SMN2 (0.59) PTPN1SMN1; SMN2HPGDLMNARAB9A
SCHEMBL3021548 0.63 LMNA (0.86) PTPN1SMN1; SMN2HPGDLMNARAB9A
SCHEMBL20964580 0.62 HPGD (0.73) SMN1; SMN2HPGDLMNARAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6531612-B2 Pyrrolidine-2-carboxylic acid cyano-methyl amide derivatives useful for treating diseases associated with cystein proteases, such as osteoporosis, osteoarthritis, rheumatoid arthritis, tumor metastasis, glomerulonephritis HOFFMAN-LA ROCHE INC. 2003-03-11 US disclosed